The role of the IGF‐I receptor in the growth and transformation of mammalian cells
- 1 February 1994
- journal article
- review article
- Published by Wiley in Cell Proliferation
- Vol. 27 (2) , 63-71
- https://doi.org/10.1111/j.1365-2184.1994.tb01406.x
Abstract
Recent developments in the molecular biology of the insulin-like growth factor I (IGF-I) receptor have clarified its role in cellular growth and transformation. Although cells homozygous for a targeted disruption of the IGF-I receptor genes can grow in serum-supplemented medium, the IGF-I receptor is required for optimal growth, and is required equally in all phases of the cell cycle. The receptor plays an even more stringent role in cellular transformation and tumorigenicity, which seem to be dependent on its normal expression in several cell types. The expression of both the IGF-I receptor and its ligands is regulated by other growth factors (especially PDGF and EGF), by oncogenes (like SV40 T antigen and c-myb) and by tumour suppressor genes (like WT1 and RB). The picture emerging from these studies is that several transforming agents may exert their growth promoting effects through the direct or indirect activation of the IGF autocrine loop.Keywords
This publication has 27 references indexed in Scilit:
- Mice carrying null mutations of the genes encoding insulinlike growth factor I (lgt-1) and type 1 IGF receptor (lgf1r)Cell, 1993
- Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformationNature, 1993
- How receptors turn Ras onNature, 1993
- Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signallingNature, 1993
- The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1Nature, 1993
- Treatment and Prevention of Rat Glioblastoma by Immunogenic C6 Cells Expressing Antisense Insulin-Like Growth Factor I RNAScience, 1993
- Repression of the Insulin-Like Growth Factor II Gene by the Wilms Tumor Suppressor WT1Science, 1992
- A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targetingNature, 1990
- Variables controlling somatomedin production by cultured human fibroblastsJournal of Cellular Physiology, 1983
- Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cellsExperimental Cell Research, 1982